Journal
British Journal of Cancer
Publication Date
2018
Volume
118
Issue
11
Inclusive Pages
1434-1441
Document Type
Open Access Publication
DOI
10.1038/s41416-018-0087-9
Rights and Permissions
Rosenberg, J. E., Hahn, N. M., Regan, M. M., Werner, L., Alva, A., George, S., . . . Choueiri, T. K. (2018). Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (borealis-2). British Journal of Cancer, 118(11): 1434-1441. doi:10.1038/s41416-018-0087-9. www.bjcancer.com This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Recommended Citation
Picus, Joel and et al, "Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2)." British Journal of Cancer. 118, 11. 1434-1441. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/6915
